These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10809693)

  • 1. Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance.
    Lee A; Mao W; Warren MS; Mistry A; Hoshino K; Okumura R; Ishida H; Lomovskaya O
    J Bacteriol; 2000 Jun; 182(11):3142-50. PubMed ID: 10809693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa.
    Li XZ; Zhang L; Poole K
    J Antimicrob Chemother; 2000 Apr; 45(4):433-6. PubMed ID: 10747818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide.
    Puzari M; Chetia P
    World J Microbiol Biotechnol; 2017 Feb; 33(2):24. PubMed ID: 28044273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring functional interplay amongst
    Goetz JA; Kuehfuss NM; Botschner AJ; Zhu S; Thompson LK; Cox G
    Microbiology (Reading); 2022 Nov; 168(11):. PubMed ID: 36318669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacterial efflux pumps - their role in antibiotic resistance and potential inhibitors].
    Hricová K; Kolář M
    Klin Mikrobiol Infekc Lek; 2014 Dec; 20(4):116-20. PubMed ID: 25702054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Lomovskaya O; Warren MS; Lee A; Galazzo J; Fronko R; Lee M; Blais J; Cho D; Chamberland S; Renau T; Leger R; Hecker S; Watkins W; Hoshino K; Ishida H; Lee VJ
    Antimicrob Agents Chemother; 2001 Jan; 45(1):105-16. PubMed ID: 11120952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan.
    Chuanchuen R; Narasaki CT; Schweizer HP
    J Bacteriol; 2002 Sep; 184(18):5036-44. PubMed ID: 12193619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial efflux systems.
    Marshall NJ; Piddock LJ
    Microbiologia; 1997 Sep; 13(3):285-300. PubMed ID: 9353747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant
    Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of OprM expression on multiple antibiotic resistance in Pseudomonas aeruginosa.
    Wong KK; Poole K; Gotoh N; Hancock RE
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2009-12. PubMed ID: 9303403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic resistance of Escherichia coli to mureidomycin A and C due to expression of the multidrug efflux system AcrAB-TolC: comparison with the efflux systems of mureidomycin-susceptible Pseudomonas aeruginosa.
    Gotoh N; Murata T; Ozaki T; Kimura T; Kondo A; Nishino T
    J Infect Chemother; 2003 Mar; 9(1):101-3. PubMed ID: 12673418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical Reconstitution and Characterization of Multicomponent Drug Efflux Transporters.
    Picard M; Tikhonova EB; Broutin I; Lu S; Verchère A; Zgurskaya HI
    Methods Mol Biol; 2018; 1700():113-145. PubMed ID: 29177829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR.
    Arabestani MR; Rajabpour M; Yousefi Mashouf R; Alikhani MY; Mousavi SM
    Arch Iran Med; 2015 Feb; 18(2):102-8. PubMed ID: 25644798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
    Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
    PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria.
    Tikhonova EB; Wang Q; Zgurskaya HI
    J Bacteriol; 2002 Dec; 184(23):6499-507. PubMed ID: 12426337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods.
    Laudy AE
    Pol J Microbiol; 2018 Jun; 67(2):129-135. PubMed ID: 30015451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins.
    Jo JT; Brinkman FS; Hancock RE
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1101-11. PubMed ID: 12604548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic export by efflux pumps affects growth of neighboring bacteria.
    Wen X; Langevin AM; Dunlop MJ
    Sci Rep; 2018 Oct; 8(1):15120. PubMed ID: 30310093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.